{"id":"https://openalex.org/W4394560933","doi":"https://doi.org/10.6084/m9.figshare.9809621","title":"Additional file 9: of Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment","display_name":"Additional file 9: of Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment","publication_year":2019,"publication_date":"2019-01-01","ids":{"openalex":"https://openalex.org/W4394560933","doi":"https://doi.org/10.6084/m9.figshare.9809621"},"language":"en","primary_location":{"id":"pmh:oai:figshare.com:article/9809621","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/Additional_file_9_of_Late-differentiated_effector_neoantigen-specific_CD8_T_cells_are_enriched_in_peripheral_blood_of_non-small_cell_lung_carcinoma_patients_responding_to_atezolizumab_treatment/9809621","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},"volume":null,"type":"dataset","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/Additional_file_9_of_Late-differentiated_effector_neoantigen-specific_CD8_T_cells_are_enriched_in_peripheral_blood_of_non-small_cell_lung_carcinoma_patients_responding_to_atezolizumab_treatment/9809621","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103148305","display_name":"Michael Fehlings","orcid":"https://orcid.org/0000-0002-0384-8408","observed_orcids":["https://orcid.org/0000-0002-0384-8408","https://orcid.org/0000-0002-5722-6364"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fehlings, Michael","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016492438","display_name":"Suchit Jhunjhunwala","orcid":"https://orcid.org/0000-0003-3484-0588","observed_orcids":["https://orcid.org/0000-0003-3484-0588"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suchit Jhunjhunwala","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001204975","display_name":"Marcin Kowanetz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kowanetz, Marcin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5095021757","display_name":"William O\u2019Gorman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O\u00e2\u0080\u0099Gorman, William","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110860414","display_name":"Priti S. Hegde","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hegde, Priti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045833655","display_name":"Hermi Sumatoh","orcid":"https://orcid.org/0000-0001-5597-2307","observed_orcids":["https://orcid.org/0000-0001-5597-2307"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sumatoh, Hermi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049484488","display_name":"Boon Heng Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Boon Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048348913","display_name":"Alessandra Nardin","orcid":"https://orcid.org/0000-0001-6832-5862","observed_orcids":["https://orcid.org/0000-0001-6832-5862"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nardin, Alessandra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030853966","display_name":"\u00c9tienne Becht","orcid":"https://orcid.org/0000-0003-1859-9202","observed_orcids":["https://orcid.org/0000-0003-1859-9202"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Becht, Etienne","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113671837","display_name":"Susan Flynn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Flynn, Susan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112302361","display_name":"Marcus D. Ballinger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ballinger, Marcus","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060666271","display_name":"Evan William Newell","orcid":"https://orcid.org/0000-0002-2889-243X","observed_orcids":["https://orcid.org/0000-0002-2889-243X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Newell, Evan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5036276427","display_name":"Mahesh Yadav","orcid":"https://orcid.org/0000-0003-2168-8177","observed_orcids":["https://orcid.org/0000-0003-2168-8177"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yadav, Mahesh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.01209999993443489,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neoantigens","display_name":"neoantigens","score":0.8519999980926514},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.9539999961853027},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9169999957084656},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9850000143051147},{"id":"https://openalex.org/keywords/tetramer-staining","display_name":"tetramer staining","score":0.5609999895095825},{"id":"https://openalex.org/keywords/viral-epitopes","display_name":"viral epitopes","score":0.9449999928474426},{"id":"https://openalex.org/keywords/immune-response","display_name":"immune response","score":0.48399999737739563},{"id":"https://openalex.org/keywords/tumor-immunology","display_name":"tumor immunology","score":0.460999995470047}],"concepts":[{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.8048592805862427},{"id":"https://openalex.org/C3017910909","wikidata":"https://www.wikidata.org/wiki/Q618363","display_name":"Peripheral blood","level":2,"score":0.6640121936798096},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.650707483291626},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.6124070286750793},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.49258118867874146},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.488810271024704},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38733792304992676},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38187354803085327},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37450918555259705},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35754430294036865},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.29921355843544006},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.25437021255493164},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23454630374908447},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.15111181139945984},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:figshare.com:article/9809621","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/Additional_file_9_of_Late-differentiated_effector_neoantigen-specific_CD8_T_cells_are_enriched_in_peripheral_blood_of_non-small_cell_lung_carcinoma_patients_responding_to_atezolizumab_treatment/9809621","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.9809621","doi":"https://doi.org/10.6084/m9.figshare.9809621","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.9809621","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.9809621.v1","doi":"https://doi.org/10.6084/m9.figshare.9809621.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.9809621.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/9809621","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/Additional_file_9_of_Late-differentiated_effector_neoantigen-specific_CD8_T_cells_are_enriched_in_peripheral_blood_of_non-small_cell_lung_carcinoma_patients_responding_to_atezolizumab_treatment/9809621","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4394431472","https://openalex.org/W4394361347","https://openalex.org/W4394318047","https://openalex.org/W2972357190","https://openalex.org/W2953622302","https://openalex.org/W2939341174","https://openalex.org/W7135035331","https://openalex.org/W4313373504","https://openalex.org/W3182507093","https://openalex.org/W4295196909"],"abstract_inverted_index":{"Table":[0],"S6.":[1],"Complete":[2],"list":[3],"of":[4],"all":[5,16],"tetramer":[6],"positive":[7],"hits":[8],"detected":[9],"for":[10,15],"neoantigens":[11],"and":[12],"viral":[13],"epitopes":[14],"patients":[17],"in":[18],"the":[19],"current":[20],"study.":[21],"(XLSX":[22],"12":[23],"kb)":[24]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2024-04-08T00:00:00"}